Recruiting now
-
HTL0039732 in Participants With Advanced Solid Tumours
Phase 2 · 150 people · 6 sites in United Kingdom · Recruiting now
-
Hyperthermia With Chemoradiotherapy in Rectal Cancer
Not phased · randomised · 264 people · 2 sites in Germany · Recruiting now
-
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
Phase 2 · 35 people · 1 site in China · Recruiting now
-
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Phase 2 · 40 people · 5 sites in United States · Recruiting now
-
Neoadjuvant Chemoradiotherapy Combined With QL1706 for MSS-Type Low-Rectal Cancer
Phase 3 · randomised · 60 people · 1 site in China · Recruiting now
-
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
Phase 2 · randomised · 57 people · 1 site in United States · Recruiting now
-
Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
Phase 2 · randomised · 130 people · 3 sites in China · Recruiting now